ClinicalTrials.Veeva

Menu

Personalized Medicine in Patients With Infective Endocarditis

F

Fundación para la Investigación Biosanitaria del Principado de Asturias

Status

Completed

Conditions

Response, Acute Phase
Treatment
Infective Endocarditis

Study type

Observational

Funder types

Other

Identifiers

NCT04838938
FINBA_critlab_4

Details and patient eligibility

About

The hypothesis underlying this work is the identification of different sub phenotypes of patients with infective endocarditis through the study of the host's response to infection.

Furthemore, metagenomic sequencing may be a helpful supplement to IE diagnostic, especially when conventional tests fail to yield a diagnosis.

Full description

Infective endocarditis is a life-threatening infection of heart valves and adjacent structures characterized by vegetations on valves and other endocardial surfaces, with tissue destruction and risk of embolization.

The clinical variability, including the heterogeneous response to infection and the different antibiotic treatments make the identification of the underlying pathogens of infective endocarditis (IE) is critical for precision therapy. Virulence factors mediate tissue adherence, host infiltration, immune resistance/evasion, and dynamic stress responses and confer enhanced pathogen survival, proliferation, and host invasion in animal models of infective endocarditis.

To identify the microorganism and simultaneously considered the response of the host to the infection could improve the management of the infective endocarditis.

Enrollment

32 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of active infective endocarditis according to the modified Duke criteria.

Exclusion criteria

  • Pregnancy

Trial contacts and locations

1

Loading...

Central trial contact

Raquel Rodríguez-García, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems